Cancer Screening is a preventive healthcare approach aimed at detecting cancer or precancerous conditions in individuals who do not yet show symptoms. Early detection through screening significantly improves treatment outcomes, survival rates, and quality of life. Common cancer screening methods include mammography for breast cancer, Pap smear and HPV testing for cervical cancer, colonoscopy and fecal tests for colorectal cancer, low-dose CT for lung cancer, and PSA testing for prostate cancer. Screening programs are often targeted based on age, gender, risk factors, and family history. From a public health perspective, organized population-based screening helps reduce cancer-related mortality and healthcare costs. However, effective screening requires evidence-based guidelines, quality assurance, informed consent, and access to follow-up care. Education and awareness are essential to increase participation and address disparities. Cancer screening remains a cornerstone of cancer prevention and early diagnosis strategies worldwide.
Title : Artificial radionuclides and evolutionary mismatch: Vulnerability of the colon, pancreas, diabetes, and arteries
Sebastiano Venturi, Department of Public Health of Rimini, Italy
Title : Specific strategies over the life course for early identification, prevention, treatment, and long-term support
Christopher Ashton, Center for Recovery, Canada
Title : Population health, public health and the social determinants of health: The state of the science
Adele Ann Webb, Strategic Education, Inc., United States
Title : The nutritional management of healthy menu plans
Iuliana Vintila, Dunărea de Jos University of Galați, Romania
Title : Healthcare system profiles and pandemic outcomes: A cross-country multi-dimensional scaling analysis of Cuba, Spain, Italy, and Germany
Giuseppe Orlando, University of Bari Aldo Moro, Italy
Title : Change your genes – change your life: Epigenetics of longevity
Kenneth R Pelletier, USCF School of Medicine, United States